Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis - sprookjes - yvandenbroek - TriplyDB

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

http://www.wikidata.org/entity/Q36245898

about

Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015 Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.Review: cancer-induced autoimmunity in the rheumatic diseases.Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.Myositis autoantibodies and clinical phenotypes.Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?Morc3 mutant mice exhibit reduced cortical area and thickness, accompanied by altered haematopoietic stem cells niche and bone cell differentiation.The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.Myositis autoantibodies.Autoantibodies in polymyositis and dermatomyositis.The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review.Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.Neuromuscular issues in systemic disease.Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.The Clinical Features of Myositis-Associated Autoantibodies: a Review.The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.The Emerging Role of MORC Family Proteins in Cancer Development and Bone Homeostasis.Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients.NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation.Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer.Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients.Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.Bench to bedside review of myositis autoantibodies.

P2860

Q21090635-8B11B7DC-37EB-45CD-AFDD-12F68AA6FB8E Q26782805-6F75C35A-0C88-4934-B186-6BA2F470A2BA Q30252086-FCC135E0-5410-40F8-96F9-9FCE3017B3E8 Q33765938-E0846901-AB5A-4BD0-BCEC-51BD215EB6FF Q33814323-D317714F-ACB7-4798-B7C7-A42FC6CA2745 Q34666066-11422C36-978B-4163-9DAC-E574ED73B30B Q35153832-A1582A3C-4EBB-44C7-8DBF-6F45598D58EC Q35281962-B4898FD9-0D38-4C6C-B97F-ADFE0CD6D0F9 Q36903076-0F628B1C-3988-4C5F-931B-1139568F2B6D Q36910565-D11B4E10-A8BE-48CA-AB37-DA72F5D53416 Q37040711-52D1E871-56AF-47A5-AD6B-B0C159959C81 Q37427265-CE181CDF-C565-491D-948A-371219DC59BC Q38041385-8A0D7409-7138-4860-9A1B-7D9F7EDA6B04 Q38099556-F3BDFE3C-2B34-42E5-9FF9-62276C261747 Q38139286-87C3A301-A72C-452A-89D6-9DA955C3A024 Q38281749-1FE19754-1FD7-43F2-80CC-677185DBDBFD Q38501865-A7714D67-0CAE-4499-9CBD-DA0E8D0262DA Q38534871-9EB26F2F-E8FC-4F42-B420-564F3D579937 Q38596370-73287955-172F-410A-910D-B9799072A937 Q38603422-7D788D89-6ED0-4F18-A5FA-6BCFD3DAF5BF Q38619523-B859C062-E7CD-4136-A410-4954403D4109 Q38646384-8E88394D-780E-466B-8E6D-549B4DD0CEBD Q38700961-BB58F04A-EF3A-4018-A993-2D9E0EC19B7A Q38803154-792A8C21-AD77-4B26-81D7-2123D4B6AB61 Q38851108-AB762653-4DF7-45C6-9960-23F4C724B0E9 Q38995102-CD7B76D2-7C5E-481A-9740-91E2DEF6BDAB Q41038527-C3135367-9A10-48FA-93FB-CACCB283EED9 Q41485219-20DC6D29-3F2D-47ED-AE13-13A2C8314BEF Q44358439-1D3F92F1-73CC-46D6-B0C9-B4109B31B866 Q47165421-10F0950F-FA66-4A5C-A38F-F3BB9929E22B Q51192752-38298373-13F7-4FCA-AE12-5CC5B9D240E8 Q51280183-2D71602E-2D79-4B5F-9452-363C8A8573A8 Q51374167-F5A51A12-3F40-4399-A9B3-3DC4C280C5E2 Q52597638-D7CA8828-66F2-4888-AD1E-11EB8CBBE157 Q54248023-2DF3BE7F-3106-413E-88C2-CFD776CBB59B Q55425108-20BBA385-A2FA-454E-BB2D-59DC5D9DAF51

P2860

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

http://www.wikidata.org/entity/Q36245898

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Anti-MJ/NXP-2 autoantibody spe ...... h polymyositis/dermatomyositis

@ast

Anti-MJ/NXP-2 autoantibody spe ...... h polymyositis/dermatomyositis

@en

type

label

Anti-MJ/NXP-2 autoantibody spe ...... h polymyositis/dermatomyositis

@ast

Anti-MJ/NXP-2 autoantibody spe ...... h polymyositis/dermatomyositis

@en

prefLabel

Anti-MJ/NXP-2 autoantibody spe ...... h polymyositis/dermatomyositis

@ast

Anti-MJ/NXP-2 autoantibody spe ...... h polymyositis/dermatomyositis

@en

P1433

Q36245898-A0B69A16-9DF4-463A-AA91-6ACB011D79A2

P1476

Q36245898-364DD8FB-1B9F-4406-B519-E09035A01396

P2093

Q36245898-476C6017-4424-4D8A-99BB-4FBB0E84F7F9

Q36245898-5DAB2EBA-1F3A-423A-B1CD-45D6AC5CBEAE

Q36245898-71A77876-0C72-48EA-9DD8-51786CF9186B

Q36245898-739E6DB6-9B11-47DF-8940-C6EE6D4DBC97

Q36245898-7EA00D80-EA90-42A1-A72D-E7CCB7B3DB16

Q36245898-9417BB59-D3EB-46EF-B5BB-F88525C3FC14

Q36245898-C8EB6983-6BFE-40B0-9C20-5486B0D2FA59

Q36245898-F4B61E03-122A-4D65-A2F6-CDE1E7C507D9

P2860

Q36245898-23275E5B-9110-43BF-9DE1-7F4388270AF9

Q36245898-47629F01-26B0-461E-AEE7-E52ED4FFAF41

Q36245898-58227D4B-0AD1-4158-953E-0D4BF569B80A

Q36245898-59A2B99C-1A98-487C-BEA1-65509FE5BE14

Q36245898-70612589-8035-4FCE-B8F1-99B3D5AA1A22

Q36245898-71273A63-E217-4F40-8FA8-4A0CEB967741

Q36245898-7E103179-F53D-474C-BF72-13368F9E0A97

Q36245898-8CBDDE58-D087-45A9-B870-976EB68B3EB3

Q36245898-A8CEBA68-3236-4051-A424-AFFCFAEDCAAA

Q36245898-B154F484-8344-4BFD-ABB3-487CA7828D36

P2888

Q36245898-7768F5CA-0709-4366-BFB2-CFBFE893A7E0

P304

Q36245898-D01B36EA-4866-44BF-8FF3-C0350041F44B

P31

Q36245898-FF927BCA-0D92-4137-B71F-85FF8562B37D

P356

Q36245898-493FC146-CF11-4DED-825C-7578B4AADD34

P433

Q36245898-B032213C-49CD-4C13-8651-9843056D728F

P478

Q36245898-5BB4261F-2D52-4300-8027-A0BA63796A31

P50

Q36245898-1E5972D2-8473-469A-87C9-3A7A20C76195

Q36245898-849AD886-313D-4FC8-97E0-93DEAB07E730

Q36245898-A0443B84-05FE-4C11-A331-F5419514D2DD

Q36245898-F383077B-6877-4700-9F23-11F9276B3277

P577

Q36245898-6B32EB80-D2EC-4932-8F60-79590265BC1A

P5875

Q36245898-E1ECDFC9-3589-4225-9347-DB2A1E130959

P698

Q36245898-7C0098AC-8D0E-4A1F-8E67-D647B3C18A8E

P921

Q36245898-45077F53-B8A1-44EA-906C-F412EA6F44BF

Q36245898-682FFC61-8993-40E2-86C2-449E4DD007B1

Q36245898-A5DFEF99-098B-431F-835B-C0E64AE0B9C5

Q36245898-B25A125F-67F6-41BF-A9D0-9A501F49B5B2

P932

Q36245898-C70CB78A-E71A-4F61-B05E-2777AA0792FC

P356

P1433

Arthritis Research and Therapy

P1476

Anti-MJ/NXP-2 autoantibody spe ...... h polymyositis/dermatomyositis

@en

P2093

Brad A Pauley

http://www.w3.org/2001/XMLSchema#string

Edward K L Chan

http://www.w3.org/2001/XMLSchema#string

Franco Franceschini

http://www.w3.org/2001/XMLSchema#string

Ilaria Cavazzana

http://www.w3.org/2001/XMLSchema#string

Jason Y F Chan

http://www.w3.org/2001/XMLSchema#string

Marzia Quinzanini

http://www.w3.org/2001/XMLSchema#string

Minoru Satoh

http://www.w3.org/2001/XMLSchema#string

Steven J Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamic regulation of p53 subnuclear localization and senescence by MORC3

NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression

Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains

Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.

Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis.

Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis.

P2888

P304

R97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3822

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Angela Ceribelli

Mara Taraborelli

P577

2012-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224870156

http://www.w3.org/2001/XMLSchema#string

P698

22546500

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis

P932

3446471

http://www.w3.org/2001/XMLSchema#string